Scheduling order sets deadlines and trial dates in Novartis Pharmaceuticals case

Jackson and other plaintiffs filed suit against Novartis Pharmaceuticals Corporation in the District of New Jersey, docket number 24-cv-09874. The case remains active with no judge assigned yet. The plaintiffs challenge Novartis on issues related to its pharmaceutical practices, though the complaint details have not been publicly disclosed.

The court recently issued a scheduling order on May 12, 2026, setting deadlines for case management and discovery. This order signals the court's intent to move the case forward toward fact-finding and potential motions. The absence of a judge assignment suggests the case is still in its early stages.

Parties will likely begin exchanging information and preparing for initial motions once a judge takes over. The docket shows no dispositive motions or trial dates yet. The case could develop quickly once the court appoints a judge and the parties complete initial disclosures.

Monitoring the assignment of a judge and any early motions will be key to understanding the case’s trajectory.